has been acquired by

August 2024  — England & Company is pleased to announce that it served as the exclusive financial advisor to Allied Bolt, Inc. (“Allied Bolt”) in its sale to Power Grid Components, Inc. (“PGC”), a portfolio company of Blackstone Energy Transition Partners. Allied Bolt, based in Port Chester, New York, is a global supplier of hardware and components for the telecommunication and power utility industries. Allied Bolt’s product categories, including earth anchors, pole line hardware, aerial drop hardware, and drop attachments, are essential to bringing high-speed data and electrical power distribution to urban and rural homes.

The acquisition of Allied Bolt expands Power Grid Component’s product offering and end markets with a trusted hardware brand, allowing it to sell more products to telecommunication and utility customers.

“I am very thankful to England & Company for putting the deal together between Allied Bolt and Power Grid Components. There is no way we could have gotten to the finish line without them. They were incredibly knowledgeable, helpful, and patient in making our transaction go smoothly,” said Glen Malin, President of Allied Bolt.  “With PGC and Blackstone, we have found partners that match our core values and goals around smart growth.”

Recapitalization by

December 2023 – England & Company is pleased to announce that it served as the exclusive financial advisor and placement agent in the debt and equity recapitalization of  OneroRx, Inc. (“OneroRx”). The financing, provided by Cyprium Investment Partners LLC (“Cyprium”) and Wells Fargo Bank, allowed OneroRx to realign its shareholder base and strengthen its balance sheet, and will enable it to continue to grow through acquisitions.

OneroRx, based in West Des Moines, IA, is a leading technology-enabled, integrated pharmacy services company operating community pharmacies and telepharmacies in underserved rural and urban areas in six states in the Midwest. In its locations, OneroRx maintains a smaller physical footprint than the national pharmacy chains and more efficient operations that enable the Company to better meet the needs of underserved communities and focus on clinical services rather than retail. The Company’s growth strategy incorporates acquisitions, building de novo sites, growing its patient base, and leveraging additional specialty services across its network.

“We have a robust M&A pipeline, and this transaction gives us the flexibility we need to position ourselves better to invest in growing the business,” said Joseph Dunham, OneroRx’s Chief Executive Officer. Dunham added, “The England team was critical in evaluating our alternatives, finding the right partners, and bringing this transaction together.”

Growth Financing

December 2023 –England & Company is pleased to announce it served as the exclusive placement agent to Power Survey and Equipment Ltd. (“Powerside“) in its successful closing of a growth equity investment from Energy Growth Momentum LLP (“EGM”). Powerside, based in Saint-Laurent, Quebec and Alameda, CA, plays a pivotal role in advancing the transformation of the industrial and utility electric power infrastructure with its unique ability to analyze, detect, and correct power quality issues arising from the increase in electric vehicles, a more distributed energy resource mix, and more renewable generation.

“We are pleased with England & Company’s service in closing a significant growth equity investment to fund Powerside’s growth initiatives with new offerings in several key markets: industrial power quality, EV infrastructure, and at the grid edge,” said Dr. Ross Dueber, CEO of Powerside. “England’s power & utility technology team was instrumental to sourcing highly qualified institutional investors, providing strategic advice and execution support throughout the transaction. Their senior bankers and deep bench are a solid complement to Powerside’s leadership team as we continue our rapid growth.”

has entered into a strategic relationship with

December 2023 – England & Company is pleased to announce that it served as the exclusive financial advisor to Extremity Medical in connection with its strategic relationship with Henry Schein, Inc. (NASDAQ: HSIC), a leading FORTUNE 500 global healthcare products and solutions company, and a new entrant complementary to Schein’s pending acquisition of TriMed, Inc.

Extremity Medical is an orthopedic medical device company specializing in extremity implants known for improved outcomes, especially in patients with poor bone quality. Based in Parsippany, NJ, Extremity Medical develops and markets proprietary, next-generation products to address fixation, fusion and motion preservation procedures in the lower and upper extremities, including the foot & ankle, hand, and wrist. It is one of the largest privately held independent companies in the U.S. serving the foot & ankle market.

Term Loan $8,000,000

December 2023– England & Company is pleased to announce it served as the exclusive advisor and placement agent to iSun, Inc. (“iSun”) (NASDAQ: ISUN) in securing an $8,000,000 senior secured loan with Decathlon Capital Partners to refinance in full the prior senior secured convertible facility which had become overly dilutive.

The transaction, which carries a 48-month term, is a straight debt instrument, thus avoiding any equity dilution. Debt service payments begin at a smaller initial level and increase over the course of the loan in several step-ups, tracking the Company’s revenue growth. Along with Decathlon’s collaborative approach and covenant-light terms, these features make this an ideal funding instrument for iSun at this stage of the company’s life.

About iSun Inc.

Since 1972, iSun has accelerated the adoption of innovations in energy transition and electrification technology. iSun has been the trusted service provider to Fortune 500 companies for decades and has installed clean rooms, fiber optic cables, flight simulators, and over 600 megawatts of solar systems. The Company currently provides a comprehensive suite of solar services across residential, commercial, industrial & municipal, and utility scale projects and provides solar electric vehicle charging solutions for both grid-tied and battery backed solar EV charging systems. iSun believes that the transition to clean, renewable solar energy is the most important investment to make today and is focused on profitable growth opportunities. Please visit www.isunenergy.com for additional information.

Convertible Notes $18,000,000

December 2023 – England & Company is pleased to announce it served as the exclusive placement agent on an $18 million in convertible notes issuance by Extremity Medical. Extremity Medical will use the new capital provided by its latest financing to invest in the growth of its business and refinance existing debt.

Extremity Medical’s innovative product portfolio includes advanced implant systems for addressing Charcot neuropathy in diabetic patients, as well as less-invasive surgical implants to correct common foot deformities, and address trauma and arthritis. Extremity Medical also offers a revolutionary total wrist replacement to restore more natural wrist motion in arthritic patients.